Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Patient Enrollment Completed for Phase III Clinical Trial of Akeso's Cadonilimab in Treatment of Gastric Cancer 2023-03-14 17:01
AnnJi Pharmaceutical Announced A Licensing Agreement With Avenue Therapeutics To Develop And Commercialize AJ201, A First-In-Class Clinical Asset For The Treatment Of Kennedy's Disease 2023-03-10 19:00
Allorion Therapeutics, a next-generation precision medicine company focusing on oncology and autoimmune diseases, raises $50 million Series B financing 2023-03-10 09:00
GenFleet Therapeutics to Present Phase I Data for GFH312 at 2023 American Society for Clinical Pharmacology & Therapeutics Meeting 2023-03-09 19:00
Estrella Biopharma Announces FDA Clearance of IND Application for Phase I/II Clinical Trial (Starlight-1) of EB103, a CD19-Targeted ARTEMIS® T Cell Therapy, to Patients with B-Cell Lymphomas 2023-03-09 05:15
Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise 2023-03-08 22:00
MSCI ESG Updated I-Mab to "A" Rating 2023-03-07 21:02
HanAll Biopharma's Licensed Partner in China Announces Positive Topline Phase 3 Results for Batoclimab in Myasthenia Gravis 2023-03-06 20:00
Porton Advanced Collaborates with DanausGT to Accelerate the Development of Gene and Cell Therapy 2023-03-02 20:00
Sanyou Biopharmaceuticals opens Cambridge MA, US office, expanding its business outreach to a central hub of biotech network 2023-03-02 18:00
111 to Announce Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results- Conference Call to Follow 2023-03-02 15:35
GenFleet receives EMA approval for phase Ib/II study of GFH925 (KRAS G12C inhibitor) in combination with ERBITUX® (cetuximab) treating patients with advanced NSCLC in first-line setting 2023-03-01 19:00
First in Class, Mabwell Announces the TGA Approval of 9MW3811 for IND 2023-02-28 23:00
Oricell Closes $45M Series B1 Financing to Expand Development of Key Products 2023-02-28 21:00
GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology 2023-02-28 08:53
China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split 2023-02-25 05:05
Oscotec Announces Topline Results for Phase 2 Trial of Cevidoplenib 2023-02-24 22:00
Porton Advanced and Yinjia Biosciences Partner to Enhance CDMO Technology Platform 2023-02-24 20:00
Dr. Lilly Xu Named President of Shanghai ChemPartner 2023-02-24 05:53
Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901 2023-02-23 13:01
1 56 57 58 59 60 165